We are live on
!
Find out more
First Trust Advisors Portfolio holdings
AUM
$140B
1-Year Est. Return
27.84%
This Fund
S&P 500
This Quarter
Est. Return
+13.34%
1 Year Est. Return
+27.84%
3 Year Est. Return
+78.79%
5 Year Est. Return
+98.89%
10 Year Est. Return
+456.9%
AUM
$91.6B
AUM Growth
+$7.27B
(+8.6%)
Cap. Flow
-$2.52B
Cap. Flow
% of AUM
-2.75%
Top 10 Holdings %
Top 10 Hldgs %
8.67%
Holding
2,485
New
145
Increased
1,032
Reduced
1,155
Closed
148
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gartner
IT
|
+$183M |
| 2 |
Ross Stores
ROST
|
+$183M |
| 3 |
Ameriprise Financial
AMP
|
+$176M |
| 4 |
United Parcel Service
UPS
|
+$175M |
| 5 |
Mondelez International
MDLZ
|
+$170M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$214M |
| 2 |
SPLK
Splunk Inc
SPLK
|
+$206M |
| 3 |
Union Pacific
UNP
|
+$191M |
| 4 |
Illinois Tool Works
ITW
|
+$184M |
| 5 |
Apple
AAPL
|
+$182M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.64% |
| 2 | Financials | 12.29% |
| 3 | Industrials | 11.25% |
| 4 | Healthcare | 9.4% |
| 5 | Consumer Discretionary | 7.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1601
Enpro
NPO
$7.05B
| $2.62M | ﹤0.01% |
16,727
-15,022
| -47% | -$1.94M |
|
1602
Extreme Networks
EXTR
$3.86B
| $2.62M | ﹤0.01% |
148,626
-41,799
| -22% | -$790K |
|
1603
Boot Barn
BOOT
$4.55B
| $2.61M | ﹤0.01% |
34,056
-11,175
| -25% | -$840K |
|
1604
Crinetics Pharmaceuticals
CRNX
$8.86B
| $2.61M | ﹤0.01% |
+73,457
| New | +$2.25M |
|
1605
Thomson Reuters
TRI
$39.4B
| $2.61M | ﹤0.01% |
17,560
-504,683
| -97% | -$68.2M |
|
1606
Vanguard Health Care ETF
VHT
$18.2B
| $2.6M | ﹤0.01% |
10,356
+4
| +0% | +$947 |
|
1607
ACV Auctions
ACVA
$1.35B
| $2.57M | ﹤0.01% |
169,632
+118,382
| +231% | +$1.73M |
|
|
HI
1608
DELISTED
Hillenbrand
HI
| $2.57M | ﹤0.01% |
53,650
-6,452
| -11% | -$264K |
|
1609
Unity
U
$12.5B
| $2.55M | ﹤0.01% |
62,311
-435,276
| -87% | -$13.4M |
|
1610
Invesco Variable Rate Investment Grade ETF
VRIG
$1.77B
| $2.53M | ﹤0.01% |
101,200
+16,300
| +19% | +$407K |
|
1611
Las Vegas Sands
LVS
$30.5B
| $2.53M | ﹤0.01% |
51,363
-313,983
| -86% | -$14.8M |
|
|
AVDX
1612
DELISTED
AvidXchange
AVDX
| $2.53M | ﹤0.01% |
203,915
-133,491
| -40% | -$1.33M |
|
1613
Sunstone Hotel Investors
SHO
$2.19B
| $2.53M | ﹤0.01% |
235,444
-90,173
| -28% | -$889K |
|
1614
iShares S&P Mid-Cap 400 Value ETF
IJJ
$8.85B
| $2.52M | ﹤0.01% |
22,119
+516
| +2% | +$53.1K |
|
1615
Cavco Industries
CVCO
$4.39B
| $2.52M | ﹤0.01% |
7,277
-6,291
| -46% | -$1.79M |
|
1616
Kinetik
KNTK
$3.71B
| $2.52M | ﹤0.01% |
75,445
-12,497
| -14% | -$437K |
|
1617
Levi Strauss
LEVI
$9.44B
| $2.51M | ﹤0.01% |
151,693
+5,390
| +4% | +$79.9K |
|
1618
National Bank Holdings
NBHC
$1.93B
| $2.51M | ﹤0.01% |
67,448
-3,067
| -4% | -$101K |
|
1619
ACM Research
ACMR
$5.83B
| $2.51M | ﹤0.01% |
128,312
+4,368
| +4% | +$76.4K |
|
1620
Cenovus Energy
CVE
$54.6B
| $2.49M | ﹤0.01% |
149,624
-77,005
| -34% | -$1.41M |
|
1621
Target Hospitality
TH
$1.61B
| $2.49M | ﹤0.01% |
256,154
-4,820
| -2% | -$59.6K |
|
1622
Recursion Pharmaceuticals
RXRX
$1.57B
| $2.49M | ﹤0.01% |
252,693
+18,271
| +8% | +$130K |
|
1623
ePlus
PLUS
$2.33B
| $2.49M | ﹤0.01% |
31,125
-8,692
| -22% | -$581K |
|
1624
Core Laboratories
CLB
$538M
| $2.48M | ﹤0.01% |
+140,701
| New | +$2.83M |
|
1625
Invesco Preferred ETF
PGX
$3.8B
| $2.48M | ﹤0.01% |
215,969
| – | – |
|
Similar funds
DAM
First Trust Advisors's Q4 2023 Portfolio in Review
As of Q4 2023, First Trust Advisors held 2,485 positions worth $91.6B, up 8.6% from $84.4B the previous quarter. Its ten largest holdings account for 8.7% of the portfolio.
First Trust Advisors's Q4 2023 filing shows 145 new, 1,032 increased, 1,155 reduced and 148 closed positions. Its largest new stake was BeOne Medicines Ltd: 219,741 shares worth $39.6M. The largest sale was Eli Lilly, an estimated $214M.
By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 29% a quarter earlier, followed by Financials and Industrials.
- First Trust Advisors's largest Q4 2023 buy was BeOne Medicines Ltd: 219,741 shares worth $39.6M.
- First Trust Advisors added most to Gartner in Q4 2023, an estimated $183M increase.
- First Trust Advisors's biggest Q4 2023 reduction was Eli Lilly, cutting an estimated $214M.
- First Trust Advisors fully exited Seagen Inc. Common Stock in Q4 2023, selling an estimated $84.9M.
- First Trust Advisors's ten largest holdings make up 8.7% of its $91.6B portfolio in Q4 2023.
- First Trust Advisors opened 145 new positions and closed 148 in Q4 2023.
- First Trust Advisors's portfolio value rose 8.6% quarter-over-quarter to $91.6B.
Based on First Trust Advisors's 13F filing for Q4 2023, filed 13 Feb 2024.